| Publication year—author (species) | Markers | Chemokines | Cytokines | Surface | Intracellular | Inducible | Excluding | Regular | Inducible |
| 2004—Katakai et al. (a) [11] (MLN) | CD44, gp38, CD106 | ER-TR7 | CD54 | CD11b/CD18, CD16,CD31, CD32, CD35, MHCII, LYVE1 | CCL2, CXCL12, CX3CL1 | CCL4, CCL5, CCL20, CXCL10 | IL6, IL7, IL15 | 2004—Katakai et al. (b) [22] (MLN) | — | ER-TR7 | — | — | — | — | — | 2005—Sixt et al. [9] (MLN) | gp38, αSMA, desmin | ER-TR7 | — | — | — | — | — | 2006—Bajénoff et al. [23] (MLN) | Desmin, CD106, CD54 | ER-TR7 | — | — | CCL19, CCL21, CXCL12 (SDF-1) | — | — | 2006—Hara et al. [25] (MLN) | gp38, CD106 | ER-TR7 | — | — | — | CXCL16 | IL7, IL15 | 2007—Amé-Thomas et al. [16] (HT) | CD73, CD90, CD105 | — | CD54 CD106 | CD21, CD23, CD35, CD45 | CCL5, CXCL9, CXCL10, CXCL12 | CCL19 | — | 2007—Link et al. [4] (MLN) | gp38, αSMA, desmin, CD157, PDGFRα, PDGFRβ, CD54, CD106, LTβR, TNF-R | ER-TR7 | — | CD21, CD31, CD35 CD45, LYVE-1 | CCL19, CCL21 | — | IL7 | 2009—Roozendaal et al. [30] (MLN) | gp38 | ER-TR7 | — | — | — | — | — | 2009—Mueller and Germain [12] (review) | gp38, PDL1 | VEGF, ER-TR7 | — | CD45, CD31, CD21, CD35, C4, CD16, CD23, CD32, CD157, Mfge8 | CCL19, CCL21 | — | IL7 |
2009—Steel et al. [17] (NHPLN) | gp38, p75NGFR, TTG, CD54, CD106, CD157, LTβR, PDGFRα, PDGFRβ, αSMA, TNFR1, Meca79, desmin | ER-TR7 | — | — | CCL19, CCL21, CXCL16, CCL2/MCP1 | — | IL7, IL6 | 2010—Turley et al. [14] (review) | gp38, PDL1 | DEAF1 | | CD31 | CCL19, CCL21 | — | IL7 | 2011—Khan et al. [15] (MLN) | gp38, PDL1 | — | iNOS | CD45, CD31 | CCL19, CCL21 | — | IL7 | 2011—Luther et al. [5] (review) | gp38, CD54, CD106, CD157, PDGFRα β, LTβR, TNFR1, desmin, αSMA | VEGF | — | CD21, CD31, CD35, CD45, C4, Mfge8 | CCL19, CCL21 | CCL2, CCL4, CCL5, CXCL12, CXCL16, CX3CL1 | IL7, IL6 | 2011—Link et al. [6] (MHLN) | gp38, CD54, CD106, CD157, PDGFRα β, LTβR, desmin, αSMA | ERTR7 | — | CD31, CD35, CD45 | CCL19, CCL21 | — | IL7 | 2011—Onder et al. [3] (MLN) | gp38 | — | — | CD31, CD45 | CCL19, CCL21 | — | IL7 | 2011—Fletcher et al. (a) [20] (MHLN) | gp38, PDGFα, CD54, CD106 | VEGF | — | CD45, CD31 | CCL19, CCL21 CXCL9, CXCL10 | — | IL7 | 2011—Fletcher et al. (b) [21] (review) | gp38, PDGFα, CD54, CD106 | VEGF | — | CD45, CD31 | CCL19, CCL21, CXCL12 (SDF1) | — | IL7 | 2011—Frontera et al. [37] (MLN) | CD54, CD106, PDGFα, CD141 | JAMC | — | CD45, CD31, LYVE1 | CCL21 | — | — | 2011—Siegert et al. [2] (MLN) | gp38 | iNOS | — | CD45, CD35, CD31, EpCAM | CCL19, CCL21 | — | IL7 |
2011—Lukacs-Kornek [34] (MLN) | gp38, PDL1, INFGR1, TNFR1, TNFR2 | NOS2, IDO | — | CD45, CD31 | CCL19, CCL21 | — | — | 2012—Zeng et al. [19] (NHPLN) | Desmin | — | — | CD35, CD21 | — | — | — | 2012—Siegert and Luther [33] (review) | gp38, PDL1 | COX2, Aire, DEAF1, NO | iNOS, MHCII, IDO, CD80 | CD21, CD35, CD31 | CCL19, CCL21 | — | IL7 |
2012—Graw and Regoes [26] (MLN) | — | — | — | — | CCL19, CCL21 | — | — | 2012—Onder et al. [29] (MLN) | gp38 | — | — | CD31, CD45 | CCL19, CCL21 | — | IL7 | 2012—Hess et al. [13] (MLN) | gp38, CD106, MadCAM1 | RankL | — | CD31, CD45 | — | — | IL7 | 2012—Malhotra et al. [28] (MLN) | gp38, CD140a | VEGFA and C, ANGPTL2 and 4, HGF, GREM1, SERPINF1 cadherin-11, IFITM-1, Flt3L | — | CD31, CD45 | CXCL14, CCL19, CCL21, CXCL13 CXCL12, CCL2, CCL7 | | IL34 | 2012—Acton et al. [24] (MLN) | gp38 | — | — | CD31 | CCL19, CCL21 | — | — | 2013—Chai et al. [31] (MLN) | gp38, αSMA, | ER-TR7, NO | — | CD31, CD45 | CCL19, CCL21 | — | IL-7 | 2014—Yang et al. [32] (MLN) | gp38, PDGFRα β, LTβR, αSMA | VEGF, iNOS, VEGF, MyD88 | — | CD31, CD45, LYVE-1 | CCL19, CCL21 | — | IL-7 |
|
|